Investigation of Treating Chronic Fatigue Syndrome After COVID With Pharmacotherapy (Pregabalin) or Complex Rehabilitation

NCT05967052 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

132

Enrollment

NETWORK

Sponsor class

Conditions

Chronic Fatigue Syndrome
COVID-19, Long Haul

Interventions

DRUG: Pregabalin
BEHAVIORAL: Independent walking training
DRUG: Placebo
BEHAVIORAL: Gradual movement therapy in the ward
BEHAVIORAL: Telerehabilitation
BEHAVIORAL: Psychotherapy

Sponsor

National Institute of Geriatrics, Rheumatology and Rehabilitation, Poland

Collaborators

[object Object]